genOway

Equities

ALGEN

FR0004053510

Biotechnology & Medical Research

Real-time Euronext Paris Other stock markets 10:33:41 2024-04-23 am EDT			5-day change	1st Jan Change
3.94 ^EUR	+1.03%		0.00%	-14.35%

2023	GenOway: sharp rise, broker initiates buy recommendation	CF
2023	GENOWAY : Euroland initiates buy coverage	CF

GenOway Société Anonyme agreed to acquire AXENIS S.A.S from Institut Pasteur de Lille for €0.19 million.

September 03, 2018

genOway Société Anonyme (ENXTPA:ALGEN) agreed to acquire AXENIS S.A.S from Institut Pasteur de Lille for €0.19 million on September 4, 2018. Genoway will issue 108,566 shares to pay for the initial purchase price.

Latest news about genOway

GenOway: sharp rise, broker initiates buy recommendation	Nov. 22	CF
GENOWAY : Euroland initiates buy coverage	Nov. 22	CF
GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI
Global markets live: Exxon Mobil, Apple, KKR, Amazon, Tesla...	23-04-11
GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-19	CI
Sigma-Aldrich and genOway Expand Their CRISPR/CAS9 Strategic Alliance	22-09-08	CI
GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
GenOway Grants the Leading UK Academic Research Funder A Non-Exclusive License for CRISPR/Cas9 Technology	22-01-25	CI
Global markets live: Michelin, Facebook, UBS, Tesla, Volvo...	21-10-26
Genoway Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-27	CI
GenOway Société anonyme announced that it has received €5.6 million in funding from NextStage AM	21-05-26	CI
GenOway Société anonyme announced that it expects to receive €5 million in funding from NextStage AM	21-05-05	CI
Genoway Soci?T? Anonyme Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
Genoway S.A. Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-17	CI
GenOway S.A. announced that it has received €1.7 million in funding from Eximium SAS, Dassault Développement and other investors	20-01-27	CI
GenOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Partnership to All Animal Cell Models	20-01-07	CI
Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models	18-12-10	CI
GenOway S.A. acquired AXENIS S.A.S from Institut Pasteur de Lille.	18-09-24	CI
GenOway Société Anonyme agreed to acquire AXENIS S.A.S from Institut Pasteur de Lille for €0.19 million.	18-09-03	CI

Chart genOway

Duration

Period

More charts

Company Profile

Sector

Biotechnology & Medical Research

Calendar

2024-06-27 - Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENOWAY	-14.35%	37.41M
IQVIA HOLDINGS INC.	+1.96%	42.11B
LONZA GROUP AG	+49.00%	40.08B
MODERNA, INC.	+7.20%	40B
CELLTRION, INC.	-11.32%	26.87B
ICON PUBLIC LIMITED COMPANY	+7.27%	24.58B
ALNYLAM PHARMACEUTICALS, INC.	-21.69%	18.44B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.33%	11.94B
MEDPACE HOLDINGS, INC.	+26.11%	11.66B
UNITED THERAPEUTICS CORPORATION	+7.98%	11.01B

Other Biotechnology & Medical Research